Dr. Sana Siddiqui, MD

Dr. Siddiqui practices at Concord Hospital Medical Associates - Concord (246 Pleasant St) in Concord, New Hampshire.

Dr. Siddiqui's NPI, 1225383516, was assigned on July 23, 2012. Dr. Siddiqui holds New Hampshire license 19918.

Dr. Siddiqui's primary practice is Concord Hospital Medical Associates - Concord (246 Pleasant St), at 246 Pleasant St Ste 205 Suite 205, Concord, NH 03301. The practice phone is (603) 224-0584. The NPI Registry lists Dr. Siddiqui's practice address as 250 Pleasant St, Concord, NH 03301.

Dr. Siddiqui's primary practice is Concord Hospital Medical Associates - Concord (246 Pleasant St) in Concord, New Hampshire. The medical group on file is Concord Hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Siddiqui practices. Vendor and product names are available with a free account.

Internal medicine is Dr. Siddiqui's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Siddiqui is licensed in New Hampshire.

CMS data shows 123 Medicare services from Dr. Siddiqui across 4 procedure codes in 2024, for 98 Medicare patients. Medicare paid $9,568 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 98 Medicare patients who saw Dr. Siddiqui in 2024. The largest group is 65 to 74, with 50 patients. 69% of them have high blood pressure, and 67% have high cholesterol. Their average risk score is 1.06, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Siddiqui's median patient age at 66, with 64% women.

In 2024, Dr. Siddiqui wrote 1,735 Medicare Part D claims for 227 patients. 90% of them were for generic drugs. CMS names the drug for 1,306 of them, across 40 drugs with 11 or more claims each, at $55,979 in total drug cost. In 2023, CMS named 1,994 claims across 51 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Siddiqui for performance year 2024, reported through an alternative payment model (APM).

Dmand AI links 11 papers to Dr. Siddiqui, published from 2022 to 2025. 2023 was the busiest year, with 4. The most frequent topics are Glycation End Products, Advanced, Molecular Docking Simulation and Pyruvaldehyde. Dr. Siddiqui has published most often in Int J Biol Macromol. Dr. Siddiqui's most frequent co-authors are Rizwan Ahmad, MD, Minhal Haider Abidi, MD and Aijaz Khan, MD.

CMS Open Payments shows 1 general payment to Dr. Siddiqui from 1 drug or device company in 2018. Food and beverage make up the largest share, 100% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $16.